Looking for a simpler clinical trial solution? We’ve got you covered. Our global network of over 150 active clinical trial sites makes it easy for us to identify potential partner sites that align with your therapeutic area, geographic preference, and specialty population requirements. Whether at one of our own clinical sites or at a partner site, we ensure to meet your timelines and budget. #ClinicalTrials #DrugDevelopment #ClinicalResearch
Altasciences
Research Services
Laval, Quebec 31,252 followers
Quicker go/no-go decisions with integrated preclinical, clinical, bioanalytical, manufacturing, and CRO services.
About us
Outsourcing made easy with a one-stop solution to early phase drug development. We are an integrated drug development solution company, offering pharmaceutical and biotechnology companies a proven, flexible approach that removes the need for multiple service providers during the early stages of drug development. Whether for one study or an end-to-end program, we help you reach critical decision-making milestones sooner by improving speed and ease from lead candidate selection to clinical proof of concept, and beyond. When partnering with Altasciences, you can experience up to 40% in time savings thanks to our integrated, one-stop solution offering. We strive to create a true partnership with our clients, our partners, and our colleagues that enables a mutually supporting relationship built on a combination of excellent science and solid communication. Helping sponsors get better drugs to the people who need them, faster, for over 25 years. Our full-service offering is always tailored to your specific research needs: - Preclinical research - Clinical pharmacology - Drug formulation - Manufacturing and analytical services - Bioanalysis - Program management - Medical writing - Biostatics - Data management - And so much more!
- Website
-
http://www.altasciences.com
External link for Altasciences
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Laval, Quebec
- Type
- Privately Held
- Founded
- 1992
- Specialties
- Clinical Research, Clinical Trials, Phase I-II, Human Abuse Liability & Abuse Potential, Early Cardiac Safety & TQT, Biosimilars, Bioanalytical Laboratory, Analytical Services, Toxicology Study, CDMO, Safety Pharmacology, Preclinical Study, GLP / Non-GLP Study, IND-Enabling, NDA Submission, LCMS and LBA, Small and Large Molecule Bioanalysis, Research Support Services, Medical Writing, Clinical Project Management, and Pharmaceutical Manufacturing
Locations
Employees at Altasciences
Updates
-
Now available on-demand! In this webinar, our experts share best practices in reducing the number of animals used in toxicology studies, while ensuring scientific integrity and reproducible findings. Watch it now: https://lnkd.in/dHaGngVW #PreclinicalResearch #Toxicology #CRO
-
-
Our scientists bring you unparalleled expertise. With a focus on scientific rigor, regulatory compliance, and operational excellence, we specialize in bioanalysis to provide the critical data needed. Our three laboratories across North America are equipped with state-of-the-art bioanalytical platforms, uniformly designed and managed to ensure consistency and reliability in every project. #DrugDevelopment #Bioanalysis #PrecisionMedicine
-
The Global Health Summit is a campaign that explores how the private sector can help drive global health in a positive direction. And for this year’s campaign, Altasciences participated in a documentary revealing how Altasciences is helping sponsors bring better drugs to the people who need them, faster. Watch the full 7-minute video on Reuters: https://lnkd.in/dTsdaHmX #DrugDevelopment #Biopharma #Biotech
-
After a long wait, the FDA has published a new draft guidance to ensure greater diversity in clinical trials. The guidance outlines how sponsors can create and implement diversity action plans to be more inclusive of underrepresented and minority populations in late-stage clinical trials, though the FDA advises sponsors to develop comprehensive strategies for the entire clinical process, including early-stages. Take a look at the full draft guidance below, which details: • diversity action plan requirements • applicable medical products and studies • submission timing and process • FDA waiver evaluation criteria #FDA #ClinicalTrials #Diversity
-
Greetings from Cambridge, UK! Let’s connect, share insights, and drive innovation. #ONHelix24 #Preclinical #Toxicology
-
-
Happy Independence Day to our American followers! Here’s to celebrating freedom with family, friends, food, and fireworks. Enjoy every moment! #IndependenceDay #WeAreAltasciences
-
Biomarker assays are essential as their ability to offer early indications of efficacy and safety significantly accelerates the overall drug development process. Our Laboratory Sciences Division has vast experience developing assays for screening, qualification, or fit-for-purpose validations. We are well-equipped to handle a wide range of biological samples, allowing for comprehensive biomarker analysis across various study types. See available assays here: https://lnkd.in/djYx7PDd Stay tuned, we have more on the way! #DrugDevelopment #Biomarkers #LifeSciences
-
Checking in today from Columbia, Missouri! Follow Larry Karnes as he takes you through a day in the life of a preclinical study director—from desk work and vivarium visits to solving Rubik's cubes and mentoring colleagues. #WeAreAltasciences #DrugDevelopment #PreclinicalResearch
-
Altascientists at all nine of our facilities recently took time to celebrate each other and the important work that we do as your partners. Here’s to many more remarkable accomplishments, and even more reasons to celebrate! #WeAreAltasciences #DrugDevelopment #TeamworkMakesTheDreamWork
-
-
-
-
-
+14
-